SurgePays, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SurgePays, Inc. (Nasdaq: SURG) on December 23, 2022, covering events that occurred on December 19, 2022. The filing details significant changes to the Company's Board of Directors and the execution of related compensatory and indemnification agreements.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignation of Director: Jay Jones resigned from the Board of Directors effective immediately on December 19, 2022. The resignation was not due to any disagreement with the Company.
- Committee Resignations: David May resigned from the Audit, Compensation, and Nominating and Corporate Governance Committees effective immediately but remains a member of the Board.
- Appointment of Directors: Laurie Weisberg and Richard Schurfeld were appointed to the Board and assigned to the Audit, Compensation, and Nominating and Corporate Governance Committees.
- Committee Leadership: Laurie Weisberg was appointed Chair of the Compensation Committee, and Richard Schurfeld was appointed Chair of the Nominating and Corporate Governance Committee.
Compensation, Outlook, and Risks
Compensatory Arrangements:
- Jay Jones (Consultant): Entered a 12-month Consulting Agreement. Compensation consists of stock options valued at $5,000 on the first trading day of each calendar month, contingent upon stockholder approval of the 2022 Omnibus Securities and Incentive Plan. Options vest immediately and are issued quarterly.
- Laurie Weisberg & Richard Schurfeld (Directors): Entered Director Agreements with terms substantially similar to Mr. Jones's arrangement. They will receive stock options valued at $5,000 monthly, subject to Incentive Plan approval. Both are reimbursed for reasonable out-of-pocket expenses and filing costs.
Indemnification: The Company entered into Indemnification Agreements with Ms. Weisberg and Mr. Schurfeld, indemnifying them to the fullest extent permitted under Nevada law for claims arising from their service as directors, excluding losses where they are adjudged liable to the Company.
Related Party Transactions: The filing states there are no family relationships between the new directors and existing management, and no material transactions involving the new directors have occurred since the beginning of the last fiscal year.
Key Facts for Investor Verification
- Verify the status of the "2022 Omnibus Securities and Incentive Plan" to confirm if stockholder approval has been obtained, as the monthly option grants for the new directors and the former director-turned-consultant are contingent upon this approval.
- Review the full text of the Consulting Agreement (Exhibit 10.1) and Director Agreements (Exhibit 10.2) for specific vesting schedules and termination clauses not detailed in the summary.
- Monitor future filings to see if the Board composition stabilizes or if further changes occur following these appointments.
- Confirm the total number of options granted under these agreements in subsequent 10-Q or 10-K filings to assess potential dilution.